Abstract: A fastener includes a head and a shaft extending from a first end to a second end. The first end is attached to the head. The shaft includes an external thread proximal the second end and a nut having an internal thread and an internal diameter. The second end of the shaft has a first condition and a second condition. In the first condition, an external diameter of the second end corresponds to the internal diameter of the nut such that the internal thread of the nut mates with the external thread of the shaft to attach the nut to the shaft. In the second condition, the external diameter of the second end is greater than the internal diameter of the nut such that the internal thread of the nut does not mate with the external thread of the shaft and the nut, once attached to the shaft, does not detach from the shaft.

Abstract: Stable formulation of L-cysteine hydrochloride amenable to terminal sterilization; a terminally sterilized stable formulation of L-cysteine hydrochloride; a process of manufacturing a stable formulation of L-cysteine hydrochloride amenable to terminal sterilization; and a container comprising the formulations of the invention.

Abstract: The present invention is directed to a process of manufacturing a pharmaceutical composition, a pharmaceutical composition produced by the process of the present invention and a container comprising a pharmaceutical composition produced by the process of the present invention.

Abstract: An optical fiber splice case particularly adapted for providing fiber optic links directly to a home, business, et al. is provided wherein an enclosure base has a dividing wall defining a drop chamber on a first side of the wall and a splicing chamber on a second side of the wall. A first and a second cover member is selectively sealingly engaged with opposing sides of the enclosure base. The enclosure base includes a bulkhead member having a plurality of optical fiber ports therethrough.

Abstract: An optical fiber splice case particularly adapted for providing fiber optic links directly to a home, business, et al. is provided wherein an enclosure base has a dividing wall defining a drop chamber on a first side of the wall and a splicing chamber on a second side of the wall. A first and a second cover member is selectively sealingly engaged with opposing sides of the enclosure base. The enclosure base includes a bulkhead member having a plurality of optical fiber ports therethrough.

Abstract: The present invention is directed to a sterile pharmaceutical composition comprising a propofol containing oil-in-water emulsion formulation having as an antimicrobial agent, a member selected from the group consisting of benzyl alcohol and ethylene diamine tetra acetic acid; benzethonium chloride; and benzyl alcohol and sodium benzoate.

Abstract: The present invention is directed to a sterile pharmaceutical composition comprising a propofol containing oil-in-water emulsion formulation having as an antimicrobial agent, a member selected from the group consisting of benzyl alcohol and sodium ethylene diamine tetraacetate; benzethonium chloride; and benzyl alcohol and sodium benzoate.